Your browser doesn't support javascript.
loading
Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief.
Shah, Shawn L; Janisch, Nigeen H; Crowell, Michael; Lacy, Brian E.
Affiliation
  • Shah SL; Division of Gastroenterology and Hepatology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York. Electronic address: shawnlshah@gmail.com.
  • Janisch NH; Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Crowell M; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona.
  • Lacy BE; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida.
Clin Gastroenterol Hepatol ; 19(1): 80-86, 2021 01.
Article in En | MEDLINE | ID: mdl-32289536
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome Type of study: Diagnostic_studies / Etiology_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome Type of study: Diagnostic_studies / Etiology_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article